Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
In the recent years, the peroxisome proliferator-activated receptor-𝛾 (PPAR-𝛾), a well known target for type II diabetes treatment, has received an increasing attention for its therapeutic potential in inflammatory and degenerative brain disorders. PPAR-𝛾 agonists, which include naturally occurring...
Saved in:
Main Authors: | Antonietta Bernardo, Luisa Minghetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/864140 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01) -
PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01) -
PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01) -
Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2
by: Joshua P. Klopper, et al.
Published: (2010-01-01) -
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)